Date published: 2026-1-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

TCP-1 ε Inhibitors

The class of TCP-1 epsilon inhibitors is composed of a range of chemicals that indirectly modulate the activity of CCT5, a molecular chaperone involved in the folding of proteins upon ATP hydrolysis. Some of these chemicals modulate CCT5 activity by targeting the cellular processes that directly or indirectly require CCT5 function. For example, Geldanamycin and Radicicol, which are Hsp90 inhibitors, impair the cooperation between Hsp90 and CCT5 in protein folding. This indirect inhibition of CCT5's function suggests that any alterations in Hsp90's activity can have a downstream effect on CCT5. Another approach to indirectly inhibit CCT5 is by modulating protein synthesis, which inherently impacts CCT5's role as a chaperone for nascent polypeptides. Cycloheximide and Puromycin, which inhibit protein synthesis by interfering with the translocation step and causing premature chain termination during translation respectively, reduce the load of nascent polypeptides and indirectly reduce CCT5 demand.

The remaining molecules, M-CPP, Rauwolscine, U0126, SB203580, PD98059, and Wortmannin, operate through modulation of intracellular signaling pathwaysthat may regulate CCT5. M-CPP and Rauwolscine affect the serotonergic and adrenergic systems respectively, leading to changes in cAMP levels, which can influence cAMP-dependent pathways that regulate CCT5. U0126, SB203580, and PD98059 are inhibitors of different components of the MAPK pathway, and thus, they can impede the upregulation of CCT5 that might be dependent on these pathways. In essence, the chemicals classified as TCP-1 epsilon inhibitors are not direct inhibitors of the chaperone itself. Instead, they exert their inhibitory effect indirectly via multiple routes. Some chemicals target the cooperative partners of CCT5, others modulate the processes that entail the demand for CCT5, while others affect the cellular signaling pathways that control CCT5 expression and activity. The understanding of these mechanisms can provide insights into the cellular roles of CCT5 and help to elucidate the broader impacts of these chemicals on cellular function.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Geldanamycin binds to Hsp90 and inhibits its function. Hsp90 interacts with CCT5 in the folding of actin and tubulin. Inhibiting Hsp90 will indirectly inhibit CCT5's function.

Radicicol

12772-57-5sc-200620
sc-200620A
1 mg
5 mg
$92.00
$333.00
13
(1)

Radicicol is another Hsp90 inhibitor which, like Geldanamycin, impairs the cooperation between Hsp90 and CCT5 in protein folding.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits protein synthesis by interfering with the translocation step in protein synthesis, reducing the load of nascent polypeptides and indirectly reducing CCT5 demand.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(15)

Puromycin causes premature chain termination during translation, reducing the load of nascent polypeptides and indirectly reducing CCT5 demand.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$70.00
$215.00
26
(2)

2-Deoxy-D-glucose inhibits glycolysis by being metabolized into 2-deoxy-D-glucose-6-phosphate, which cannot undergo further glycolysis. This reduces ATP levels, indirectly inhibiting ATP-dependent chaperones like CCT5.

Oligomycin

1404-19-9sc-203342
sc-203342C
10 mg
1 g
$149.00
$12495.00
18
(2)

Oligomycin inhibits ATP synthase, reducing the ATP levels in the cell and indirectly inhibiting ATP-dependent chaperones like CCT5.

1-(3-Chlorophenyl)piperazine

6640-24-0sc-206098
5 mg
$330.00
(1)

This compound, also caled M-CPP, inhibits serotonin receptor 2C (5-HT_2C). Reduced 5-HT_2C activity leads to reduced cAMP levels, which can indirectly inhibit cAMP-dependent pathways that may upregulate CCT5.

Rauwolscine • HCl

6211-32-1sc-200151
100 mg
$107.00
(1)

Rauwolscine is an α2-adrenergic receptor antagonist. Antagonism of this receptor increases cAMP levels, which can indirectly inhibit cAMP-dependent pathways that may upregulate CCT5.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 inhibits p38 MAPK, which can impede p38 MAPK-dependent upregulation of CCT5.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is a selective ERK pathway inhibitor, blocking MEK activation and thus impeding MEK-dependent upregulation of CCT5.